# STOCKHOLM 1.0
#=GF ID   GBP
#=GF AC   PF02263.23
#=GF DE   Guanylate-binding protein, N-terminal domain
#=GF AU   Bateman A;0000-0002-6982-4660
#=GF AU   Mian N;0000-0003-4284-4749
#=GF AU   Griffiths-Jones SR;0000-0001-6043-807X
#=GF SE   Pfam-B_4308 (release 5.2) & Pfam-B_9065 (release 8.0)
#=GF GA   21.10 21.10;
#=GF TC   21.10 21.10;
#=GF NC   21.00 21.00;
#=GF BM   hmmbuild HMM.ann SEED.ann
#=GF SM   hmmsearch --cpu 4 -E 1000 -Z 75585367 HMM pfamseq
#=GF TP   Domain
#=GF WK   Guanylate-binding_protein
#=GF CL   CL0023
#=GF RN   [1]
#=GF RM   10676968
#=GF RT   Structure of human guanylate-binding protein 1 representing a
#=GF RT   unique class of GTP-binding proteins. 
#=GF RA   Prakash B, Praefcke GJ, Renault L, Wittinghofer A, Herrmann C; 
#=GF RL   Nature 2000;403:567-571.
#=GF DR   INTERPRO; IPR015894;
#=GF DR   SCOP; 1dg3; fa;
#=GF DR   SO; 0000417; polypeptide_domain;
#=GF CC   Transcription of the anti-viral guanylate-binding protein (GBP)
#=GF CC   is induced by interferon-gamma during macrophage induction. This
#=GF CC   family contains GBP1 and GPB2, both GTPases capable of binding
#=GF CC   GTP, GDP and GMP.
#=GF SQ   11
#=GS GBP2_HUMAN/18-280    AC P32456.3
#=GS GBP1_MOUSE/18-280    AC Q01514.1
#=GS GBP1_HUMAN/18-282    AC P32455.2
#=GS GBP7_HUMAN/18-281    AC Q8N8V2.2
#=GS GBP7_MOUSE/18-281    AC Q91Z40.2
#=GS GBP4_MOUSE/12-275    AC Q61107.1
#=GS Q9BMU4_CAEEL/43-325  AC Q9BMU4.1
#=GS ATLAS_DROME/14-289   AC Q9VC57.1
#=GS ATLA2_HUMAN/70-341   AC Q8NHH9.2
#=GS ATLA1_HUMAN/43-314   AC Q8WXF7.1
#=GS GBP5_HUMAN/18-280    AC Q96PP8.1
GBP2_HUMAN/18-280               KGQLVVNPEALKIL....SAITQPVVVVAIVGLYRTGKSYLMNKLAG...........................KKNGFSLGSTVKSHTKGIWMWCVP....HPKKPEHTLVLLDTEGLGDIEKGDNENDSWIFALAILLSSTFVYNSMGTINQQAMDQLHYVTELTDRIKANSS..PGNNSVDDSADFVSFFPAFVWTLRDFTLELEVDGEPITADDYLELSLKLRKGTDKKSKSFNDPRLCIRKFFPKRKCFVFDWPAPKKYL.AHLEQLKEEELNPDFIEQVAEFCSYILS.HSNVKTL
GBP1_MOUSE/18-280               EAQLVINQEALRIL....SAITQPVVVVAIVGLYRTGKSYLMNKLAG...........................KRTGFSLGSTVQSHTKGIWMWCVP....HPKKAGQTLVLLDTEGLEDVEKGDNQNDCWIFALAVLLSSTFIYNSIGTINQQAMDQLHYVTELTDLIKSKSS..PDQSDVDNSANFVGFFPIFVWTLRDFSLDLEFDGESITPDEYLETSLALRKGTDENTKKFNMPRLCIRKFFPKRKCFIFDRPGDRKQL.SKLEWIQEDQLNKEFVEQVAEFTSYIFS.YSGVKTL
GBP1_HUMAN/18-282               NGRLMANPEALKIL....SAITQPMVVVAIVGLYRTGKSYLMNKLAG...........................KKKGFSLGSTVQSHTKGIWMWCVP....HPKKPGHILVLLDTEGLGDVEKGDNQNDSWIFALAVLLSSTFVYNSIGTINQQAMDQLYYVTELTHRIRSKSSPDENENEVEDSADFVSFFPDFVWTLRDFSLDLEADGQPLTPDEYLTYSLKLKKGTSQKDETFNLPRLCIRKFFPKKKCFVFDRPVHRRKL.AQLEKLQDEELDPEFVQQVADFCSYIFS.NSKTKTL
GBP7_HUMAN/18-281               KGHLVVNSEALEIL....SAITQPVVVVAIVGLYRTGKSYLMNKLAG...........................KNKGFPLGCTVKSETKGIWMWCVP....HPSKPNHTLILLDTEGLGDMEKSDPKSDSWIFALAVLLSSSFVYNSMGTINHQALEQLHYVTELTELIRAKSC..PRPDEVEDSSEFVSFFPDFIWTVRDFTLELKLDGHPITEDEYLENALKLISGKNPQIQNSNKPREWIRHFFPKQKCFVFDRPINDKKLLLHVEEVREDQLDSNFQMQSENFCSYIFT.HAKTKTL
GBP7_MOUSE/18-281               NEELRVNSKAINIL....ERITQPVVVVAIVGLYRTGKSYLMNRLAG...........................QNHGFNLGTTVRSETKGIWMWCVP....HPSKPKFTLVLLDTEGLGDVEKGDPKNDSWIFALAVLLSSTFVYNSMSTINHQALEQLHYVTELTERIRAKST..SRSEEVDDSDEFVSFFPDFIWTVRDFVLELKLEGRVITADEYLENALKLIPGMSIKAQKANLPRECIRHFFPRRKCFVFDRPTKDKELLVHVEEMPEDQLDHSFQVQSKEFCSYIFS.NSKAKTL
GBP4_MOUSE/12-275               KNQLTVNLEAIRIL....EQIAQPLVVVAIVGLYRTGKSYLMNRLAG...........................RNHGFSLGSTVQSETKGIWMWCVP....HPTKPTHTLVLLDTEGLGDVEKGDPKNDSWIFALAVLLSSTFVYNSMSTINQQALEQLHFVTELTQLIRAKSS..PREDKVKDSSEFVGFFPDFIWAVRDFALELKLNGRPITEDEYLENALKLIQGDNLKVQQSNMTRECIRYFFPVRKCFVFDRPTSDKRLLLQIENVPENQLERNFQVESEKFCSYIFT.NGKTKTL
Q9BMU4_CAEEL/43-325             DHSFELNTELLEKILLDPKVADKKVAVIGVAGAYRKGKSFLLNFFLRYLTWRSKADKVMGEVELDNSQWMSPNSPLSGFSWRGGSERDTNGILIWSEPFIMKDKNGEEIAVLLMDTQGAFD.SQSTVKDCATIFALSTMISSVQIYNLSQNIQEDDLQHLQLFTE..............YGRLALEDSASKPFQSLLFLVRDWSFPYEAEFGFQGGQRVLDRRLEVSEKQHAELQQ...LRQHIRSCFEDIRCFLMPHPGLKVATNPNFDG.KLVDIENEFQQQLGVMIPRLLDSHALVHKE
ATLAS_DROME/14-289              EHTFVLNEDALSEVLMRDEVKDRFVCVVSVAGAFRKGKSFLLDFFLRYMYSKYVHHD.......ATDWLGGESDPLEGFSWRGGSERDTTGILMWSDIFLHDYPNGDKIAIILLDTQGAFD.SQSTVRDCATVFALSTMLSSVQIYNLSQNIQEDDLQHLQLFTE..............YGRLALADTGKKPFQRLQFLVRDWSFPYEAEYGALGGDKILKRRLEVSDKQHPELQS...LRRHISSCFTEVACFLMPHPGLNVATNPKFDG.RLQDITPEFKSSLRSLVPMLLAPDNLVYKE
ATLA2_HUMAN/70-341              DHNFELDEEALEQILLQEHIRDLNIVVVSVAGAFRKGKSFLLDFMLRYMYNKDSQ...........SWIGGNNEPLTGFTWRGGCERETTGIQVWNEVFVIDRPNGTKVAVLLMDTQGAFD.SQSTIKDCATVFALSTMTSSVQVYNLSQNIQEDDLQHLQLFTE..............YGRLAMEEIYQKPFQTLMFLIRDWSYPYEHSYGLEGGKQFLEKRLQVKQNQHEELQN...VRKHIHNCFSNLGCFLLPHPGLKVATNPSFDG.RLKDIDEDFKRELRNLVPLLLAPENLVEKE
ATLA1_HUMAN/43-314              DHSFELDETALNRILLSEAVRDKEVVAVSVAGAFRKGKSFLMDFMLRYMYNQESV...........DWVGDYNEPLTGFSWRGGSERETTGIQIWSEIFLINKPDGKKVAVLLMDTQGTFD.SQSTLRDSATVFALSTMISSIQVYNLSQNVQEDDLQHLQLFTE..............YGRLAMEETFLKPFQSLIFLVRDWSFPYEFSYGADGGAKFLEKRLKVSGNQHEELQN...VRKHIHSCFTNISCFLLPHPGLKVATNPNFDG.KLKEIDDEFIKNLKILIPWLLSPESLDIKE
GBP5_HUMAN/18-280               NEQLKVNQEALEIL....SAITQPVVVVAIVGLYRTGKSYLMNKLAG...........................KNKGFSVASTVQSHTKGIWIWCVP....HPNWPNHTLVLLDTEGLGDVEKADNKNDIQIFALALLLSSTFVYNTVNKIDQGAIDLLHNVTELTDLLKARNS..PDLDRVEDPADSASFFPDLVWTLRDFCLGLEIDGQLVTPDEYLENSLRPKQGSDQRVQNFNLPRLCIQKFFPKKKCFIFDLPAHQKKL.AQLETLPDDELEPEFVQQVTEFCSYIFS.HSMTKTL
#=GC seq_cons                   cppLhlNpEALcIL....psIsQPVVVVAIVGLYRTGKSYLMN+LAG...........................pppGFSluuTVcS-TKGIWMWCVP....HPstsphsLlLLDTEGLtDhEKuDs+sDuhIFALAlLLSSoFVYNohssIsppAL-pLahVTELTphl+upss...t.scVcsussFluFFPshlWslRDFoLsLEh-GpslTsD-YLEpuL+lppGpctclQs.N.sRppIRpFFPcpKCFlFD+Puhc+tL.splEthp-c-L-s-FhpQlppFsSYIho.cuhsKTL
